Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL988628 | 0.86 | SLC6A9 (0.64) | SLC6A9CYP3A4NPC1BDKRB1 | |
| SCHEMBL989642 | 0.86 | NPC1 (0.41) | SLC6A9NPC1BDKRB1KLKB1 | |
| SCHEMBL12096133 | 0.77 | SLC6A9 (0.67) | SLC6A9CYP3A4 | |
| Hydrochloric Acid SCHEMBL4257506 | 0.76 | SLC6A9 (0.66) | SLC6A9CYP3A4 | |
| SCHEMBL988871 | 0.76 | SLC6A2 (0.39) | SLC6A9CYP3A4 | |
| SCHEMBL988862 | 0.76 | SLC6A9 (0.65) | SLC6A9CYP3A4NPC1 | |
| SCHEMBL988895 | 0.76 | SLC6A9 (0.71) | SLC6A9CYP3A4NPC1 | |
| Hydrochloric Acid SCHEMBL989909 | 0.75 | SLC6A9 (0.64) | SLC6A9CYP3A4NPC1 | |
| SCHEMBL989560 | 0.75 | F10 (0.42) | NPC1 | |
| SCHEMBL989898 | 0.75 | PDK2 (0.39) | SLC6A9CYP3A4NPC1BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271625-A2 | TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | Abbott GmbH & Co. KG (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009121872-A2 | TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | ABBOTT GMBH & CO. KG (DE) | 2009-10-08 | — | — | WO | disclosed |